← All sectors
Biotech & Pharma: companies
Daily −0.63%Weekly −2.48%Monthly −4.13%266 companies · ₩228T
Korean Biotech & Pharma stocks: sector overview
The Biotech & Pharma sector has 266 companies listed on KOSPI and KOSDAQ, worth ₩228T in total. On Oct 29, 2026 the group moved down 0.63% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.
Key facts
- Stocks
- 266
- Total market value
- ₩228T
- Day's move
- −0.63%
- As of
- Oct 29, 2026
- Largest members
- Samsung Biologics, Celltrion, Alteogen
Earnings tracker · 3Q 2026
Reporting season · reports due by Nov 14
13 of 266 reportedOperating profit up vs a year ago: 7 of 11
Revenue+17.9%
Operating profit+46.7%
Net profit+26.3%
Combined, for the companies that have reported, vs the same quarter a year ago
| Company | Reported | Revenue | vs a year ago | Operating profit | vs a year ago | vs last quarter | Op. margin |
|---|---|---|---|---|---|---|---|
| Celltrion | Oct 12Preliminary | ₩1.5T | +45.8% | ₩510B | +69.2% | +12.9% | 34.0%29.3% |
| Yuhan | Oct 28Preliminary | ₩586B | +2.8% | ₩35B | +57.8% | −48.0% | 5.9%3.9% |
| Hanmi Pharm | Oct 27Preliminary | ₩377B | +4.2% | ₩38B | −31.3% | −71.2% | 10.0%15.2% |
| ST Pharm | Oct 27Preliminary | ₩98B | +19.1% | ₩16B | +6.6% | −14.3% | 16.1%18.0% |
| Boryung | Oct 22Preliminary | ₩314B | +12.3% | ₩25B | −13.4% | +7.1% | 8.1%10.5% |
| Bukwang Pharmaceutical IND | Oct 23Preliminary | ₩58B | +21.2% | ₩2.2B | +120.7% | +53.3% | 3.7%2.0% |
| Dong-A ST | Oct 27Preliminary | ₩207B | −4.4% | ₩21B | +52.9% | +239.9% | 10.4%6.5% |
| KolmarBNH | Oct 29Preliminary | ₩115B | −24.4% | ₩11B | +13.7% | +8.7% | 9.6%6.4% |
| Whanin Pharm | Oct 29Preliminary | ₩72B | +8.9% | ₩7.5B | +111.8% | −4.6% | 10.5%5.4% |
| Kyongbo Pharmaceutical | Oct 30Preliminary | ₩66B | −1.2% | ₩100M | −78.9% | −89.3% | 0.2%0.7% |
| T&R Biofab | Oct 19Preliminary | ₩8.9B | +28.1% | — | — | — | — |
| CKD Bio | Oct 30Preliminary | ₩29B | −14.0% | −₩6B | Bigger loss | Bigger loss | −20.4%−4.3% |
| Shaperon | Oct 1Preliminary | ₩4.7B | +2,683.4% | — | — | — | — |
| Hyundai Pharmaceutical | Expected around Oct 15 | ||||||
| Samsung Biologics | Expected around Oct 28 | ||||||
| Hanall Biopharma | Expected around Oct 29 | ||||||
| HK inno.N | Expected around Oct 29 | ||||||
| Onconic Therapeutics | Expected around Oct 30 | ||||||
| Korea United Pharm | Expected around Oct 30 | ||||||
| Handok | Expected around Oct 30 | ||||||
| Myungin Pharm | Expected around Oct 31 | ||||||
| Bioneercorporation | Expected around Oct 31 | ||||||
| Samik Pharm | Expected around Oct 31 | ||||||
| Abion | Expected around Oct 31 | ||||||
| SK Bioscience | Expected around Nov 3 | ||||||
| GC Biopharma | Expected around Nov 3 | ||||||
| Chong Kun Dang Pharmaceutical | Expected around Nov 3 | ||||||
| JW Pharmaceutical | Expected around Nov 3 | ||||||
| GC WellBeing | Expected around Nov 3 | ||||||
| Choong ANG Vaccine Laboratory | Expected around Nov 3 | ||||||
| GC Medical Science | Expected around Nov 3 | ||||||
| Hugel | Expected around Nov 4 | ||||||
| SK biopharmaceuticals | Expected around Nov 5 | ||||||
| Yungjin Pharm | Expected around Nov 5 | ||||||
| JW Lifescience | Expected around Nov 5 | ||||||
| JW Shinyak | Expected around Nov 5 | ||||||
| IL Dong Pharmaceutical | Expected around Nov 6 | ||||||
| Rokit Healthcare | Expected around Nov 6 | ||||||
| ISU Abxis | Expected around Nov 6 | ||||||
| Cell Biotech | Expected around Nov 6 | ||||||
| Ildong Holdings | Expected around Nov 6 | ||||||
| Seegene | Expected around Nov 7 | ||||||
| Daewoong Pharma | Expected around Nov 7 | ||||||
| Boditech Med | Expected around Nov 7 | ||||||
| NeoImmuneTech | Expected around Nov 7 | ||||||
| QuadMedicine | Expected around Nov 7 | ||||||
| Medy-Tox | Expected around Nov 10 | ||||||
| AbClon | Expected around Nov 10 | ||||||
| EuBiologics | Expected around Nov 10 | ||||||
| Huons | Expected around Nov 10 | ||||||
| Vivozon Pharmaceutical | Expected around Nov 10 | ||||||
| Eye Gene | Expected around Nov 10 | ||||||
| Daesung Microbiological Labs | Expected around Nov 10 | ||||||
| PharmaResearch | Expected around Nov 11 | ||||||
| ABL Bio | Expected around Nov 11 | ||||||
| Rznomics | Expected around Nov 11 | ||||||
| Pharos iBio | Expected around Nov 11 | ||||||
| Olipass | Expected around Nov 11 | ||||||
| OSCOTECInc | Expected around Nov 12 | ||||||
| MedPacto | Expected around Nov 12 | ||||||
| Bio-Fd&C | Expected around Nov 12 | ||||||
| CTC Bio | Expected around Nov 12 | ||||||
| Gencurix | Expected around Nov 12 | ||||||
| Chabiotech | Expected around Nov 13 | ||||||
| G2GBIO | Expected around Nov 13 | ||||||
| Curocell | Expected around Nov 13 | ||||||
| AprilBio | Expected around Nov 13 | ||||||
| 3billion | Expected around Nov 13 | ||||||
| DuChemBio | Expected around Nov 13 | ||||||
| Kangstem Biotech | Expected around Nov 13 | ||||||
| Ilyang Pharmaceutical | Expected around Nov 13 | ||||||
| Kukjeon | Expected around Nov 13 | ||||||
| ViGenCell | Expected around Nov 13 | ||||||
| Genexine | Expected around Nov 13 | ||||||
| DreamCIS | Expected around Nov 13 | ||||||
| Aribiolab | Expected around Nov 13 | ||||||
| Sam-A Pharm | Expected around Nov 13 | ||||||
| Shinil Pharmaceutical | Expected around Nov 13 | ||||||
| Daehan Nupharm | Expected around Nov 13 | ||||||
| DongKook Life Science | Expected around Nov 13 | ||||||
| SunBio | Expected around Nov 13 | ||||||
| CMG Pharmaceutical | Expected around Nov 13 | ||||||
| Pangen Biotech | Expected around Nov 13 | ||||||
| Cytogen | Expected around Nov 13 | ||||||
| KoBioLabs | Expected around Nov 13 | ||||||
| Hwail Pharm | Expected around Nov 13 | ||||||
| Aprogen Biologics | Expected around Nov 13 | ||||||
| Wonbiogen | Expected around Nov 13 | ||||||
| Eutilex | Expected around Nov 13 | ||||||
| Biotoxtech | Expected around Nov 13 | ||||||
| Poongjeon Pharmacy | Expected around Nov 13 | ||||||
| Alteogen | Expected around Nov 14 | ||||||
| HLB | Expected around Nov 14 | ||||||
| SAM Chun Dang Pharm | Expected around Nov 14 | ||||||
| LigaChem Biosciences | Expected around Nov 14 | ||||||
| Peptron | Expected around Nov 14 | ||||||
| OliX Pharmaceuticals | Expected around Nov 14 | ||||||
| Voronoi | Expected around Nov 14 | ||||||
| D&D Pharmatech | Expected around Nov 14 | ||||||
| Caregen | Expected around Nov 14 | ||||||
| Celltrion Pharm | Expected around Nov 14 | ||||||
| Mezzion Pharma | Expected around Nov 14 | ||||||
| Naturecell | Expected around Nov 14 | ||||||
| Kolon TissueGene | Expected around Nov 14 | ||||||
| DongKook Pharmaceutical | Expected around Nov 14 | ||||||
| Daewoong | Expected around Nov 14 | ||||||
| JS Link | Expected around Nov 14 | ||||||
| L&C Bio | Expected around Nov 14 | ||||||
| Qurient | Expected around Nov 14 | ||||||
| Komipharm International | Expected around Nov 14 | ||||||
| Proteina | Expected around Nov 14 | ||||||
| GI Innovation | Expected around Nov 14 | ||||||
| Shinpoong Pharmaceutical | Expected around Nov 14 | ||||||
| HLB Pharmaceutical | Expected around Nov 14 | ||||||
| HLB Life Science | Expected around Nov 14 | ||||||
| Penetrium Bioscience | Expected around Nov 14 | ||||||
| T&L | Expected around Nov 14 | ||||||
| Orum Therapeutics | Expected around Nov 14 | ||||||
| Medipostco | Expected around Nov 14 | ||||||
| Kwangdong Pharmaceutical | Expected around Nov 14 | ||||||
| ToolGen | Expected around Nov 14 | ||||||
| SillaJen | Expected around Nov 14 | ||||||
| NKGen Biotech Korea | Expected around Nov 14 | ||||||
| Huons Global | Expected around Nov 14 | ||||||
| Samjin Pharmaceutical | Expected around Nov 14 | ||||||
| Humedix | Expected around Nov 14 | ||||||
| Genomictree | Expected around Nov 14 | ||||||
| S.Biomedics | Expected around Nov 14 | ||||||
| ImmuneOncia Therapeutics | Expected around Nov 14 | ||||||
| IntoCell | Expected around Nov 14 | ||||||
| Ilsung IS | Expected around Nov 14 | ||||||
| FutureChem | Expected around Nov 14 | ||||||
| Jetema | Expected around Nov 14 | ||||||
| BioPlus | Expected around Nov 14 | ||||||
| Binex | Expected around Nov 14 | ||||||
| Union Korea Pharm | Expected around Nov 14 | ||||||
| Genome&Company | Expected around Nov 14 | ||||||
| curacle | Expected around Nov 14 | ||||||
| Chongkundang Holdings | Expected around Nov 14 | ||||||
| DAE HWA Pharm | Expected around Nov 14 | ||||||
| Reyon Pharmaceutical | Expected around Nov 14 | ||||||
| Kolon Life Science | Expected around Nov 14 | ||||||
| Eone Diagnomics Genome Center | Expected around Nov 14 | ||||||
| Helixmith | Expected around Nov 14 | ||||||
| Samil Pharmaceutical | Expected around Nov 14 | ||||||
| BNC Korea | Expected around Nov 14 | ||||||
| Cellbion | Expected around Nov 14 | ||||||
| Nibec | Expected around Nov 14 | ||||||
| Kyungdong Pharm | Expected around Nov 14 | ||||||
| Daehan Pharmaceutical | Expected around Nov 14 | ||||||
| Aptabio Therapeutics | Expected around Nov 14 | ||||||
| Hana Pharm | Expected around Nov 14 | ||||||
| Dongwha Pharm | Expected around Nov 14 | ||||||
| Y-Biologics | Expected around Nov 14 | ||||||
| Bio Solution | Expected around Nov 14 | ||||||
| Jeil Pharmaceutical | Expected around Nov 14 | ||||||
| Ahn-Gook Pharmaceutical | Expected around Nov 14 | ||||||
| Dongsung Pharmaceutical | Expected around Nov 14 | ||||||
| Samsung Pharmaceutical | Expected around Nov 14 | ||||||
| TiumBio | Expected around Nov 14 | ||||||
| Keeps Biopharma | Expected around Nov 14 | ||||||
| Optus Pharmaceutical | Expected around Nov 14 | ||||||
| Celemics | Expected around Nov 14 | ||||||
| Sewoonmedical | Expected around Nov 14 | ||||||
| Asta | Expected around Nov 14 | ||||||
| Metabiomed | Expected around Nov 14 | ||||||
| High Tech Pharm | Expected around Nov 14 | ||||||
| Prestige Biologics | Expected around Nov 14 | ||||||
| HLB bioStep | Expected around Nov 14 | ||||||
| Aminologics | Expected around Nov 14 | ||||||
| DongKoo Bio & Pharma | Expected around Nov 14 | ||||||
| iNtRON Biotechnology | Expected around Nov 14 | ||||||
| Vaxcell-Bio Therapeutics | Expected around Nov 14 | ||||||
| Corestemchemon | Expected around Nov 14 | ||||||
| Korea Pharma | Expected around Nov 14 | ||||||
| Cellumed | Expected around Nov 14 | ||||||
| Withus Pharmaceutical | Expected around Nov 14 | ||||||
| Enzychem Lifesciences | Expected around Nov 14 | ||||||
| SCL Science | Expected around Nov 14 | ||||||
| Polaris AI Pharma | Expected around Nov 14 | ||||||
| HLB Genex | Expected around Nov 14 | ||||||
| Daebonglsco | Expected around Nov 14 | ||||||
| Theragen Etex | Expected around Nov 14 | ||||||
| Kukje Pharma | Expected around Nov 14 | ||||||
| Choolip & Sciences | Expected around Nov 14 | ||||||
| Sugentech | Expected around Nov 14 | ||||||
| Access Bio | Expected around Nov 14 | ||||||
| CG Invites | Expected around Nov 14 | ||||||
| Naturalendo Tech | Expected around Nov 14 | ||||||
| Optipharm | Expected around Nov 14 | ||||||
| PharmGen Science | Expected around Nov 14 | ||||||
| Sinsin Pharmaceutical | Expected around Nov 14 | ||||||
| Adbiotech | Expected around Nov 14 | ||||||
| Tego Science | Expected around Nov 14 | ||||||
| Humasis | Expected around Nov 14 | ||||||
| HLB Panagene | Expected around Nov 14 | ||||||
| Yuyu Pharma | Expected around Nov 14 | ||||||
| Cellid | Expected around Nov 14 | ||||||
| ENCell | Expected around Nov 14 | ||||||
| Geninus | Expected around Nov 14 | ||||||
| JIN Yang Pharmaceutical | Expected around Nov 14 | ||||||
| Aprogen | Expected around Nov 14 | ||||||
| GeneOne Life Science | Expected around Nov 14 | ||||||
| CJ Bioscience | Expected around Nov 14 | ||||||
| RPbio | Expected around Nov 14 | ||||||
| Quratis | Expected around Nov 14 | ||||||
| Green Lifescience | Expected around Nov 14 | ||||||
| Oncocross | Expected around Nov 14 | ||||||
| Myungmoon Pharm | Expected around Nov 14 | ||||||
| HLB Pep | Expected around Nov 14 | ||||||
| Organoidsciences | Expected around Nov 14 | ||||||
| Orientbio | Expected around Nov 14 | ||||||
| Kainos Medicine | Expected around Nov 14 | ||||||
| Kolmar BioTech | Expected around Nov 14 | ||||||
| IMBdx | Expected around Nov 14 | ||||||
| Kyung NAM Pharm | Expected around Nov 14 | ||||||
| Hass | Expected around Nov 14 | ||||||
| Genolution | Expected around Nov 14 | ||||||
| Korean Drug | Expected around Nov 14 | ||||||
| Bcworldpharm | Expected around Nov 14 | ||||||
| LabGenomics | Expected around Nov 14 | ||||||
| Genematrix | Expected around Nov 14 | ||||||
| Korea Arlico Pharm | Expected around Nov 14 | ||||||
| Tdspharm | Expected around Nov 14 | ||||||
| Dt&Cro | Expected around Nov 14 | ||||||
| Seoul Pharma | Expected around Nov 14 | ||||||
| WooGene B&Gco | Expected around Nov 14 | ||||||
| MFC | Expected around Nov 14 | ||||||
| Telcon RF Pharmaceutical | Expected around Nov 14 | ||||||
| Xcell Therapeutics | Expected around Nov 14 | ||||||
| PCL | Expected around Nov 14 | ||||||
| PeopleBio | Expected around Nov 14 | ||||||
| Celestra | Expected around Nov 14 | ||||||
| ChoA Pharmaceutical | Expected around Nov 14 | ||||||
| BioInfra | Expected around Nov 14 | ||||||
| MOA Life Plus | Expected around Nov 14 | ||||||
| It-Chem | Expected around Nov 28 | ||||||
| Prestige BioPharma | Expected around Nov 28 | ||||||
| HEM Pharma | Expected around Nov 28 | ||||||
| Inventage Lab | Expected around Dec 1 | ||||||
| Hans Biomed | Expected around Dec 18 | ||||||
| Aimed Bio | Not yet | ||||||
| Ingenia Therapeutics | Not yet | ||||||
| BioNote | Not yet | ||||||
| Samyang Biopharm | Not yet | ||||||
| IMBiologics | Not yet | ||||||
| Daewon Pharmaceutical | Not yet | ||||||
| Ensol Biosciences | Not yet | ||||||
| Kanaph Therapeutics | Not yet | ||||||
| Pharmaresearch Bio | Not yet | ||||||
| Inventera | Not yet | ||||||
| Imgt | Not yet | ||||||
| HL Genomics | Not yet | ||||||
| Epi Biotech | Not yet | ||||||
| NovMetaPharma | Not yet | ||||||
| ProGen | Not yet | ||||||
| BASKHANBIOPharma | Not yet | ||||||
| Plumbline Life Sciences | Not yet | ||||||
| Moogene Medi | Not yet | ||||||
| Curachem | Not yet | ||||||
| Invites Biocore | Not yet | ||||||
| AngioLab | Not yet | ||||||
| Median Diagnostics | Not yet | ||||||
| Cronex | Not yet | ||||||
| Medizen Humancare | Not yet | ||||||
| BioInfra Life Science | Not yet | ||||||
Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.
Technical breadth
After the close on Oct 29, 2026- Above 20-day average
- 9.9%
- Above 60-day average
- 17.2%
- RSI above 70
- 0.4%
- RSI below 30
- 11.6%
- 52-week highs
- 0
- 52-week lows
- 20
Index gauge · Short term
Bearish
0 bullish, 2 neutral, 7 bearish
Index gauge · Medium term
Bearish
0 bullish, 1 neutral, 7 bearish
Technical read
The Biotech & Pharma group covers 232 Korean members, and only 9.9% of them trade above their 20-day averages while 17.2% sit above their 60-day averages. Breadth is weak across the board, with 20 members at 52-week lows and none at 52-week highs, and the share of members with extreme RSI readings is very low at 0.4% on the high side and 11.6% on the low side. The equal-weighted member index shows bearish readings on both short-term (7 bearish signals, 0 bullish, 2 neutral) and medium-term (7 bearish, 0 bullish, 1 neutral) gauges, with an RSI of 35.3 and the index trading below its cloud.
Written by AI from the indicator values above. Not advice.
Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Credit & macro
- MaturitiesOct 23, 202685ISU Abxis: ₩50bn of bonds due in the next 6 months vs ₩23bn cash₩50bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.ISU Abxis
- MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
- MaturitiesOct 22, 202675Boryung: ₩86bn of bonds due in the next 6 months vs ₩50bn cash₩86bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.Boryung
- MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK ReitSK hynixSK NetworksSK DiscoverySKCSK Telecom
| Company | Price | Daily | Weekly | Monthly | Traded value | Market cap | NPS |
|---|---|---|---|---|---|---|---|
Samsung Biologics207940 · KOSPI | ₩1,366,000 | −0.44% | +0.37% | −2.43% | ₩58B | ₩63T | 6.88% |
Celltrion068270 · KOSPI | ₩189,300 | −0.26% | −2.57% | +6.17% | ₩71B | ₩44T | 7.28% |
SK biopharmaceuticals326030 · KOSPI | ₩77,800 | +3.46% | +3.87% | +2.10% | ₩16B | ₩6.1T | 6.00% |
Yuhan000100 · KOSPI | ₩74,700 | −3.36% | −11.07% | 0.00% | ₩24B | ₩5.5T | 6.83% |
Hanmi Pharm128940 · KOSPI | ₩388,500 | +5.14% | +4.86% | −22.92% | ₩63B | ₩5T | 9.61% |
SK Bioscience302440 · KOSPI | ₩32,200 | +0.16% | −6.94% | −11.66% | ₩2.2B | ₩2.5T | 5.50% |
PharmaResearch214450 · KOSDAQ | ₩222,500 | −2.63% | −12.75% | −30.47% | ₩21B | ₩2.3T | 7.14% |
OliX Pharmaceuticals226950 · KOSDAQ | ₩96,500 | −0.82% | −8.62% | −7.57% | ₩15B | ₩2.2T | 5.04% |
Hanall Biopharma009420 · KOSPI | ₩37,800 | −1.82% | −6.20% | −12.90% | ₩7.9B | ₩2T | 10.56% |
ST Pharm237690 · KOSDAQ | ₩74,000 | −4.15% | −17.59% | −20.52% | ₩9.1B | ₩1.5T | 5.77% |
GC Biopharma006280 · KOSPI | ₩132,000 | +1.15% | +0.76% | +7.14% | ₩1.9B | ₩1.5T | 6.68% |
Daewoong Pharma069620 · KOSPI | ₩101,500 | +1.60% | −1.36% | −6.28% | ₩1.7B | ₩1.2T | 10.30% |
HK inno.N195940 · KOSDAQ | ₩34,650 | −0.14% | +1.61% | −11.72% | ₩3.4B | ₩982B | 5.03% |
Chong Kun Dang Pharmaceutical185750 · KOSPI | ₩62,500 | +0.97% | −4.14% | −4.43% | ₩703M | ₩863B | 6.34% |
JS Link127120 · KOSDAQ | ₩19,200 | +3.06% | +12.54% | −40.37% | ₩3.4B | ₩718B | 5.05% |
Source: KRX statistical information